Evidence map›Paper›PMID 28765278›Full record

ArticleThe Journal of biological chemistry2017

The peroxisomal matrix protein translocon is a large cavity-forming protein assembly into which PEX5 protein enters to release its cargo.

Ana F Dias, Tony A Rodrigues, Ana G Pedrosa, Aurora Barros-Barbosa, Tânia Francisco, Jorge E Azevedo

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The peroxisome: an update on mysteries 3.0.Histochemistry and cell biology · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. The peroxisome: an update on mysteries 2.0.Histochemistry and cell biology · 2018
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana F DiasFrom the Instituto de Investigação e Inovação em Saúde (i3S) and.ORCID 0000-0002-6667-1961
Tony A RodriguesFrom the Instituto de Investigação e Inovação em Saúde (i3S) and.ORCID 0000-0003-2311-8258
Ana G PedrosaFrom the Instituto de Investigação e Inovação em Saúde (i3S) and.ORCID 0000-0001-8887-2046
Aurora Barros-BarbosaFrom the Instituto de Investigação e Inovação em Saúde (i3S) and.ORCID 0000-0003-4484-4427
Tânia FranciscoFrom the Instituto de Investigação e Inovação em Saúde (i3S) and.ORCID 0000-0003-3571-5164
Jorge E AzevedoFrom the Instituto de Investigação e Inovação em Saúde (i3S) and jazevedo@ibmc.up.pt.ORCID 0000-0001-7714-5302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A remarkable property of the machinery for import of peroxisomal matrix proteins is that it can accept already folded proteins as substrates. This import involves binding of newly synthesized proteins by cytosolic peroxisomal biogenesis factor 5 (PEX5) followed by insertion of the PEX5-cargo complex into the peroxisomal membrane at the docking/translocation module (DTM). However, how these processes occur remains largely unknown. Here, we used truncated PEX5 molecules to probe the DTM architecture. We found that the DTM can accommodate a larger number of truncated PEX5 molecules comprising amino acid residues 1-197 than full-length PEX5 molecules. A shorter PEX5 version (PEX5(1-125)) still interacted correctly with the DTM; however, this species was largely accessible to exogenously added proteinase K, suggesting that this protease can access the DTM occupied by a small PEX5 protein. Interestingly, the PEX5(1-125)-DTM interaction was inhibited by a polypeptide comprising PEX5 residues 138-639. Apparently, the DTM can recruit soluble PEX5 through interactions with different PEX5 domains, suggesting that the PEX5-DTM interactions are to some degree fuzzy. Finally, we found that the interaction between PEX5 and PEX14, a major DTM component, is stable at pH 11.5. Thus, there is no reason to assume that the hitherto intriguing resistance of DTM-bound PEX5 to alkaline extraction reflects its direct contact with the peroxisomal lipid bilayer. Collectively, these results suggest that the DTM is best described as a large cavity-forming protein assembly into which cytosolic PEX5 can enter to release its cargo.

Indexed as

Models, BiologicalAmino Acid MotifsAmino Acid SubstitutionBiological TransportEndopeptidase KGene DeletionHumansHydrogen-Ion ConcentrationIntracellular MembranesMembrane ProteinsMutagenesis, Site-DirectedMutationMutation, MissensePeptide FragmentsPeroxisomesPeroxisome-Targeting Signal 1 ReceptorEndopeptidase KMembrane ProteinsPeptide FragmentsPeroxisome-Targeting Signal 1 ReceptorPEX13 protein, humanPEX14 protein, humanPEX5 protein, humanReceptors, Cytoplasmic and NuclearRecombinant Fusion ProteinsRecombinant ProteinsRepressor Proteinsdocking/translocation moduleperoxisomePEX14PEX5protein importprotein sortingreceptor recyclingubiquitylation (ubiquitination)

Identifiers

PMID28765278
PMCPMC5602389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.